readthroughSign in
CompanyXERSNasdaqChicago, IL

Xeris Biopharma Holdings, Inc.

Xeris Biopharma commercializes Recorlev for Cushing's syndrome, Gvoke (liquid glucagon) for severe hypoglycemia, and Keveyis for primary periodic paralysis.

10-QNov 5Latest SEC filing
Nov 3Latest story